Famotidine 30mg Extended-Release Tablets from Japan
Extended-release famotidine 30mg tablets provide 24-hour control of acid production for chronic GERD patients. Containing famotidine in retail-measured doses, they are under HTS 3004.90.92.54.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Pharmacokinetic studies proving extended-release profile for classification support
• Matrix polymer content declaration to avoid parts classification